Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420147 | SCV000525557 | benign | not specified | 2018-03-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001083075 | SCV000654332 | benign | Developmental and epileptic encephalopathy 94 | 2024-01-27 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000711185 | SCV000841516 | benign | not provided | 2018-05-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313078 | SCV000847456 | likely benign | Inborn genetic diseases | 2016-07-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |